Seres Therapeutics, Inc. Current Liabilities
Seres Therapeutics, Inc. (MCRB) had Current Liabilities of $20.03 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $20.03M.
- 2026-03-31: Liabilities, Current $19.34M.
- 2025-12-31: Liabilities, Current $19.32M.
- 2025-09-30: Liabilities, Current $22.43M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $20.03M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $19.34M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $19.32M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $22.43M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $30.94M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $31.32M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $41.22M 10-K · filed 2026-03-12 |
| 2024-09-30 | $64.83M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $108.28M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $98.48M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $98.66M 10-K · filed 2025-03-13 |
| 2023-09-30 | $79.22M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $77.90M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $63.82M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $85.60M 8-K · filed 2024-08-15 |
| 2022-09-30 | $81.82M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $89.04M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $82.36M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $82.26M 10-K · filed 2023-03-07 |
| 2021-09-30 | $94.59M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $56.16M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $47.86M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $46.41M 10-K · filed 2022-03-01 |
| 2020-09-30 | $45.77M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $44.25M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $44.11M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $45.99M 10-K · filed 2021-03-02 |
| 2019-09-30 | $42.24M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $43.07M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $41.57M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $42.04M 10-K · filed 2020-03-02 |
| 2018-09-30 | $39.01M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $36.77M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $35.15M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $31.63M 10-K · filed 2019-03-06 |
| 2017-09-30 | $27.03M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $25.66M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $27.24M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $30.46M 10-K · filed 2018-03-08 |
| 2016-09-30 | $31.88M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $27.33M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $24.82M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $10.92M 10-K · filed 2017-03-16 |
| 2015-09-30 | $4.85M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.64M 10-Q · filed 2015-08-10 |
| 2014-12-31 | $5.10M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |